Description
Nineless A-Control Azelaic Acid Cream (50ml) is a multi-functional moisturiser designed to target blemishes, refine skin texture and provide long-lasting hydration.
Formulated with 10,000ppm of Azelaic Acid, it works to visibly brighten the complexion, minimise breakouts and even out skin tone. Calming Panthenol (3,000ppm) helps to strengthen the skin barrier, while Snail Secretion Filtrate supports skin regeneration, elasticity and moisture retention. Lactic Acid gently smooths and softens, revealing a more refined texture, and antioxidant-rich Green Tea and Pine Leaf Extracts protect against environmental stressors.
The lightweight, non-comedogenic texture absorbs effortlessly, making it suitable for all skin types, including sensitive and blemish-prone skin. With consistent use, skin appears clearer, more balanced and visibly healthier. Cruelty-free & vegan-friendly.
Directions of use:
Use in the morning and evening as the final step in your skincare routine.
Apply a moderate amount and gently massage into the skin until fully absorbed.
Perform a patch test on the wrist or behind the ear before first use.
Ingredients
Ingredients & Product Highlights The list of ingredients is subject to change, it recommended review the ingredient printed on packaging product prior usage or consumption. If doesn't load below, please email our customer care team and we'll send an image packaging. WATER ISODODECANE DIMETHICONE AZELAIC ACID BUTYLENE GLYCOL GLYCERIN AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER SODIUM POLYACRYLATE DIPROPYLENE ETHYLHEXYL STEARATE PANTHENOL DIMETHICONE/VINYL CROSSPOLYMER PEG-100 GLYCERYL HYDROXYACETOPHENONE ETHYLHEXYLGLYCERIN CAPRYLHYDROXAMIC CAPRYLYL TRIDECETH-6 1,2-HEXANEDIOL DISODIUM EDTA SNAIL SECRETION FILTRATE LACTIC DECYL GLUCOSIDE POLYGLYCERYL-6 CAPRYLATE POLYGLYCERYL-4 CAPRATE SALIX ALBA BARK EXTRACT CLADOSIPHON OKAMURANUS CENTELLA ASIATICA LEAF CAMELLIA SINENSIS COFFEA ARABICA FRUIT CITRUS AURANTIUM BERGAMIA PINUS DENSIFLORA Nut-Free


Reviews
Clear filtersThere are no reviews yet.